FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting

Posted on AllSides December 17th, 2020
From The Left

A second COVID-19 vaccine likely will receive a thumbs up Thursday from an advisory committee to the U.S. Food and Drug Administration, which authorized the first one a week ago.

This time, the committee is reviewing a vaccine made by Cambridge, Massachusetts, biotech Moderna, with similar technology and results as the one it supported last week by Pfizer and its German collaborator, BioNTech.

A clinical trial in 30,000 volunteers showed that the Moderna vaccine is more than 94% effective in preventing COVID-19, including serious disease. The vaccine causes frequent...

Read full story
Some content from this outlet may be limited or behind a paywall.
https://www.usatoday.com/story/news/health/2020/12/17/moderna-covid-19-vaccine-fda-final-review-authorization/6538175002/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right